These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32288744)
1. [Modulation of transcriptomic signature of the infected host: a new therapeutic strategy for the management of severe viral infections? Example of the flu]. Poissy J; Terrier O; Lina B; Textoris J; Rosa-Calatrava M Reanimation; 2016; 25(Suppl 2):53-61. PubMed ID: 32288744 [TBL] [Abstract][Full Text] [Related]
2. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures. Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M Front Immunol; 2019; 10():60. PubMed ID: 30761132 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
5. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Witvrouw M; De Clercq E Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294 [TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
8. Targeting Importin-α7 as a Therapeutic Approach against Pandemic Influenza Viruses. Resa-Infante P; Paterson D; Bonet J; Otte A; Oliva B; Fodor E; Gabriel G J Virol; 2015 Sep; 89(17):9010-20. PubMed ID: 26085167 [TBL] [Abstract][Full Text] [Related]
9. Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches. Cakir M; Obernier K; Forget A; Krogan NJ mSystems; 2021 Oct; 6(5):e0038821. PubMed ID: 34519533 [TBL] [Abstract][Full Text] [Related]
10. Clinical development of microbicides for the prevention of HIV infection. D'Cruz OJ; Uckun FM Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390 [TBL] [Abstract][Full Text] [Related]
11. Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses. Aggarwal M; Leser GP; Lamb RA J Virol; 2020 Feb; 94(6):. PubMed ID: 31896588 [TBL] [Abstract][Full Text] [Related]
12. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus. Gasparini R; Amicizia D; Lai PL; Bragazzi NL; Panatto D J Prev Med Hyg; 2014 Dec; 55(4):109-29. PubMed ID: 26137785 [TBL] [Abstract][Full Text] [Related]
13. In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data. Das S; Camphausen K; Shankavaram U Res Sq; 2020 Jun; ():. PubMed ID: 32702730 [TBL] [Abstract][Full Text] [Related]
14. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498 [TBL] [Abstract][Full Text] [Related]
15. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses. Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593 [TBL] [Abstract][Full Text] [Related]
16. [Prospects for development of new antituberculous drugs]. Tomioka H Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850 [TBL] [Abstract][Full Text] [Related]
17. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease. Shoaib M; Kamal MA; Rizvi SMD Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531 [TBL] [Abstract][Full Text] [Related]
18. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of viral emergence and interspecies transmission: the exemple of simian foamy viruses in Central Africa]. Gessain A Bull Acad Natl Med; 2013 Dec; 197(9):1655-67; discussion 1667-8. PubMed ID: 26137812 [TBL] [Abstract][Full Text] [Related]